ARTICLE | Clinical News
PTI-801: PTIE will begin this quarter a U.K. Phase II trial of PTI-801.
January 22, 2002 8:00 AM UTC
Pain Therapeutics Inc. (PTIE), South San Francisco, Calif. Product: PTI-801 Business: Neurological Therapeutic category: Analgesic, Receptor agonist Target: Opioid receptors Description: Immediate rel...